A randomized, controlled comparison of different intensive lipid-lowering therapies in Chinese patients with non-ST-elevation acute coronary syndrome (NSTE-ACS): Ezetimibe and rosuvastatin versus high-dose rosuvastatin.

Ran, Dan; Nie, Hui-Juan; Gao, Yu-Lin; Deng, Song-Bai; Du, Jian-Lin; Liu, Ya-Jie; Jing, Xiao-Dong; She, Qiang

Ran, Dan; Nie, Hui-Juan; Gao, Yu-Lin; Deng, Song-Bai; Du, Jian-Lin; Liu, Ya-Jie; Jing, Xiao-Dong; She, Qiang.

Afiliação

Ran D; The Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China; The Department of Cardiology, The Pengzhou People's Hospital, Sichuan, China.
Nie HJ; The Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Gao YL; The Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Deng SB; The Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Du JL; The Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Liu YJ; The Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jing XD; The Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
She Q; The Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Electronic address: qshe98@hotmail.com.

Int J Cardiol ; 235: 49-55, 2017 May 15.

Article em En | MEDLINE | ID: mdl-28291622

Assuntos

Síndrome Coronariana Aguda; LDL-Colesterol/sangue; Ezetimiba; Rosuvastatina Cálcica; Síndrome Coronariana Aguda/sangue; Síndrome Coronariana Aguda/diagnóstico; Síndrome Coronariana Aguda/epidemiologia; Síndrome Coronariana Aguda/prevenção & controle; Idoso; Anticolesterolemiantes/administração & dosagem; Anticolesterolemiantes/efeitos adversos; Proteína C-Reativa/análise; China/epidemiologia; Relação Dose-Resposta a Droga; Monitoramento de Medicamentos/métodos; Quimioterapia Combinada/métodos; Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/epidemiologia; Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/etiologia; Eletrocardiografia/métodos; Ezetimiba/administração & dosagem; Ezetimiba/efeitos adversos; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Rosuvastatina Cálcica/administração & dosagem; Rosuvastatina Cálcica/efeitos adversos

Palavras-chave

Ezetimibe; Intensive lipid-lowering therapy; Rosuvastatin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Coronariana Aguda / Rosuvastatina Cálcica / Ezetimiba / LDL-Colesterol Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google